Literature DB >> 11323153

Treatment of central post-stroke pain with oral ketamine.

P G Vick1, T J Lamer.   

Abstract

Case report of 68 year old female with central post-stroke pain successfully treated with oral ketamine. The patient's pain was refractory to conventional pain treatments and she had persistent right hemi-body neuropathic pain with allodynia and hyperalgesia. An intravenous ketamine trial, followed by oral ketamine with titration to 50mg three times a day was beneficial in decreasing allodynia and hyperalgesia, as well as improving functional capabilities. Known side effects including dysphoria, hallucinations, and paranoid feelings were attenuated with benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323153     DOI: 10.1016/s0304-3959(00)00488-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

Review 1.  Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome.

Authors:  Eliezer Soto; Douglas R Stewart; Andrew J Mannes; Sarah L Ruppert; Karen Baker; Daniel Zlott; Daniel Handel; Ann M Berger
Journal:  Am J Hosp Palliat Care       Date:  2011-07-29       Impact factor: 2.500

Review 2.  Updates in the Treatment of Post-Stroke Pain.

Authors:  Alyson R Plecash; Amokrane Chebini; Alvin Ip; Joshua J Lai; Andrew A Mattar; Jason Randhawa; Thalia S Field
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

Review 3.  Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies.

Authors:  Katharine N Gurba; Rida Chaudhry; Simon Haroutounian
Journal:  CNS Drugs       Date:  2022-05-05       Impact factor: 6.497

Review 4.  Central poststroke pain: an abstruse outcome.

Authors:  James L Henry; Chitra Lalloo; Kiran Yashpal
Journal:  Pain Res Manag       Date:  2008 Jan-Feb       Impact factor: 3.037

Review 5.  Pharmacotherapy to Manage Central Post-Stroke Pain.

Authors:  Hanwool Ryan Choi; Adem Aktas; Michael M Bottros
Journal:  CNS Drugs       Date:  2021-02-07       Impact factor: 5.749

Review 6.  N-methyl-D-aspartate- enhanced analgesia.

Authors:  David J Hewitt
Journal:  Curr Pain Headache Rep       Date:  2003-02

7.  Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine.

Authors:  Aude Castel; Pierre Hélie; Francis Beaudry; Pascal Vachon
Journal:  BMC Vet Res       Date:  2013-03-27       Impact factor: 2.741

8.  Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression.

Authors:  Joanna Szarmach; Wiesław Jerzy Cubała; Adam Włodarczyk; Maria Gałuszko-Węgielnik
Journal:  Medicina (Kaunas)       Date:  2021-03-16       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.